The Department of Health and Human Services (HHS) awarded a Firm Fixed Price purchase order contract to Qiagen Beverly, LLC, a foreign-owned for-profit manufacturer, for $272,250.00 to provide BioWatch inventory. Qiagen Beverly, LLC has previously received other HHS awards to support the BioWatch program, a nationwide biosurveillance system to detect intentional release of biological agents. The contract does not have a set-aside designation. Additional details on the specific products or...
This federal contract award was made by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Administration to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, for $231,990.00. The contract is for the provision of BioWatch inventory, which supports the BioWatch program, a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents. This award did not have a set-aside designation. Qiagen Beverly, LLC is a...
The Department of Health and Human Services (HHS) awarded a $331,000.00 Firm Fixed Price purchase order to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, for the provision of lab supplies. This award is not associated with any set-aside designation. Qiagen Beverly, LLC has previously received awards from HHS and the Department of the Air Force Materiel Command to provide products and services in support of the BioWatch program, a nationwide biosurveillance system to detect the...
This is a $165,197.49 firm fixed-price purchase order awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer. The contract is for the provision of lab supplies, with no set-aside designation. Past awards to Qiagen Beverly, LLC have primarily supported the HHS BioWatch program, a nationwide biosurveillance system to detect the intentional release of aerosolized biological agents. This includes purchase orders for BioWatch...
The U.S. Department of Health and Human Services (HHS) awarded a $231,000.00 firm-fixed-price purchase order to Qiagen Beverly, LLC, a foreign-owned, for-profit manufacturer, to provide laboratory supplies in support of the BioWatch program. The BioWatch program is a nationwide biosurveillance system operated by HHS to detect the intentional release of aerosolized biological agents. This award is one of several contracts Qiagen Beverly, LLC has received from HHS to support the BioWatch...
This $158,946.49 firm-fixed price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is for the provision of laboratory supplies, which are likely to support HHS's biosurveillance and COVID-19 testing efforts, such as the BioWatch program operated by HHS. Qiagen Beverly has received several previous awards from HHS and the Department of the Air Force to supply...
This is a firm-fixed price purchase order awarded by the Department of Health and Human Services (HHS) to Qiagen Beverly, LLC, a division of the parent company Qiagen N.V. The contract, valued at $165,155.23, is for the supply of laboratory supplies to support biosurveillance and COVID-19 testing efforts. Qiagen Beverly primarily provides products to the BioWatch program, a nationwide biosurveillance system operated by HHS to detect the intentional release of biological agents. The company has...
The Department of Health and Human Services awarded a $243,600 firm fixed price purchase order to Qiagen Beverly, LLC for the BIOWATCH program. As the prime contractor, Qiagen Beverly will provide unspecified services or products to the Office of the Assistant Secretary for Administration in support of biosurveillance efforts. Performance will take place in Beverly, Massachusetts over a two week period concluding at the end of December 2023. No major subcontractors or set aside designations were...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $55,000.00 firm fixed price purchase order contract to Qiagen, LLC, a division of Qiagen N.V., an international provider of sample and assay technologies for molecular diagnostics, applied testing, pharma, and academics. This contract has a completion date of May 21, 2024. Qiagen is a foreign-owned, for-profit manufacturer that has provided a range of products and services to support federal...
This $23,248.02 firm fixed-price purchase order was awarded by the Department of Health and Human Services (HHS) to Qiagen, LLC, a division of the multinational biotechnology company Qiagen N.V. The contract is not set aside. Qiagen provides sample and assay technologies, molecular diagnostics, and related products and services to support federal agencies' biomedical research, public health, law enforcement, and healthcare programs. This award is likely part of a larger indefinite delivery...